Concord Wealth Partners Ishares Biotechnology ETF Transaction History
Concord Wealth Partners
- $710 Million
- Q3 2025
A detailed history of Concord Wealth Partners transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Concord Wealth Partners holds 39 shares of IBB stock, worth $6,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$6,403
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IBB
# of Institutions
962Shares Held
33.2MCall Options Held
3.72MPut Options Held
2.68M-
Bank Of America Corp Charlotte, NC5.89MShares$968 Million0.06% of portfolio
-
Citigroup Inc3.72MShares$611 Million0.25% of portfolio
-
Morgan Stanley New York, NY3.13MShares$513 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY2.55MShares$418 Million0.05% of portfolio
-
Ubs Group Ag1.09MShares$179 Million0.03% of portfolio